FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer

Cisplatin is commonly used in ovarian cancer chemotherapy, however, chemoresistance to cisplatin remains a great clinical challenge. Oncogenic transcriptional factor FOXM1 has been reported to be overexpressed in ovarian cancer. In this study, we aimed to investigate the potential role of FOXM1 in o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jinhua, Wang, Yunfei, Wang, You, Yin, Xia, He, Yifeng, Chen, Lilan, Wang, Wenwen, Liu, Ting, Di, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019642/
https://www.ncbi.nlm.nih.gov/pubmed/24824601
http://dx.doi.org/10.1371/journal.pone.0096989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019642/
https://www.ncbi.nlm.nih.gov/pubmed/24824601
http://dx.doi.org/10.1371/journal.pone.0096989

Ejemplares similares